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ABSTRACT
Infertility, according to the World Health Organization, is defined as the failure to conceive after
twelve months of regular unprotected sexual intercourse. A recent study measuring the
prevalence of female infertility estimated that 48.5 million women were affected globally (World
Health Organization). To even begin to understand infertility is a colossal undertaking. Before
we can hope to cure this disorder in humans we must first understand its pathogenesis in animal
models. For this purpose, a study will be undertaken in zebrafish, Danio rerio, a popular model
organism for reproductive studies (Segner, 2009). Based on a previous study in mouse models
the ICER (inducible cAMP early repressor) protein has been identified as a potentiator of
hyperovulation in mice (Muñiz). The ICER protein is an inducible early repressor of the cAMP
second messenger system and a dominant negative autoregulator of its own expression (Molina,
1993). Based on the results of the Muñiz study, the present research will focus on the expression
of ICER in zebrafish ovaries. First, it was proven via protein and RNA expression analysis that
ICER is expressed in a stage-dependent manner in the zebrafish ovary during folliculogenesis.
Next, based on this expression profiling, an ICER plasmid vector was designed with ICER under
the control of the cyp19a1 ovarian-specific promoter. Cyp19a1 is a gonadotropin and estrogen
inducible promoter predominantly expressed in the zebrafish ovary (Kazeto, 2001). This plasmid
vector can be utilized in the future, in conjunction with the Tol2 transposase system in zebrafish,
to study the effects of ICER overexpression in the ovary and hopefully elucidate some further
understanding of the causes and pathology of infertility as well as possible treatment scenarios
(Kawakami, 2007).
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INTRODUCTION
Infertility is a leading cause of distress among families in the modern world. The
emotional toll cannot be quantified in numbers or enumerated by statistics. The sorrow is
unique to each couple as they struggle to understand their inability to conceive. The causes
are complex, the etiology a labyrinthine web. While science cannot begin to understand the
poignant burden carried by these families, we can only hope to offer solace and solutions.
Solace, that we are learning more about infertility with each passing day, and solutions,
that modern medicine has within its grasp the ability to help any couple conceive.
Infertility, according to the World Health Organization, is defined as the failure to
conceive after twelve months of regular unprotected sexual intercourse. A recent study
measuring the prevalence of female infertility estimated that 48.5 million women were
affected globally. Among women aged 20-44 1.9% were unable to conceive a first child,
and among women who had had a first child 10.5% were unable to have a second child.
These are termed primary and secondary infertility (Mascarenhas, 2012). Female age is
widely known to be the single most important factor in conception, showing a gradual
decline with age, and a sharp decline after 35 (Maheshwari, 2008). There is an increasing
trend among women to delay childbearing often into the thirties and even forties. Given
this trend, women should be made aware of the possibility of the rapid onset and loss of
fertility in the mid to late thirties. A study from the NCHS finds the rate of women with
impaired fecundity doubles from 16% at ages 25-34 to 33% at ages 35-44. The rate of
spontaneous pregnancy loss mirrors this, with the rate nearly doubling from 17% at ages
25-34 to 31% at ages 35-44 (Mosher, 1988).





A recent review found the five most common diagnoses at presentation of infertility
to be: ovulatory dysfunction (23.6% <35 yrs, 11.4% >35 yrs), endometriosis (4.5% <35
yrs, 3.1% >35 yrs), tubal factor (17.6% <35 yrs, 24.8% >35 yrs), unexplained (21.0% <35
yrs, 26.6% >35 yrs), and male factor (35.0% <35 yrs, 32.5% >35 yrs) (Maheshwari, 2008).
Some data suggest that unexplained infertility is caused by diminished ovarian reserve.
Premature ovarian failure is a disorder which causes ovarian loss of function before the age
of 40. This disorder affects 1/10,000 women at age 20, 1/1,000 women at age 30 and 1/100
women at age 40 (Goswami, 2005).
While infertility continues to be a problem for many families worldwide, there are
treatments available. According to the Society for Assisted Reproductive Technology
(ART), 71,296 babies were born as the result of 242,168 ART cycles in the United States
in 2016. In a year in which 3,945,875 babies were born in the United States this accounts
for 1.8% of births (www.sart.org, www.cdc.gov).
The Endocrine System
Infertility at its core is a disruption of the normal functioning of the reproductive
system. Reproduction is a fundamental component of life, and sexually reproducing
organisms make a heavy investment into passing on their genetic material to the next
generation. Due to its critical importance, the reproductive system is under tight regulatory
control and the neuroendocrine system is the master regulator of this arena. The endocrine
system is a chemical messenger system consisting of hormones, the glands which secrete
those hormones, and the feedback loops of homeostasis that the hormones drive. The
hypothalamus, in vertebrates, is the neural control center of the endocrine systems. All





animals with a nervous system have a neuroendocrine system and all vertebrates have a
hypothalamus pituitary axis (Hartenstein, 2006).
The hypothalamic-pituitary-gonadal (HPG) axis consists of the hypothalamus and
the pituitary gland and gonadal glands: the ovaries and testis. The hormones which make
up the HPG axis are gonadotropin releasing hormone (GnRH) secreted by the
hypothalamus, the gonadotropins (GTH): follicle stimulating hormone (FSH) and
luteinizing hormone (LH) secreted by the anterior pituitary gland (APG), and estrogen and
testosterone secreted by the gonads.
Focusing on the gonads, and more specifically the ovaries, can serve to highlight
the complex homeostasis which the endocrine systems maintains. In the ovaries, FSH and
LH stimulate the ovaries to produce estrogen and inhibin. Estrogen then forms a negative
feedback loop by inhibiting production of GnRH in the hypothalamus. Inhibin, inhibits
activin, a peripherally produced hormone that positively stimulates GnRH producing cells
(Mukherjee et al., 1998; Wang et al., 2004). Meanwhile, a positive feedback loop between
LH and estrogen helps prepare the ovary and uterus for ovulation and implantation. When
the egg is released the empty follicle then begins to produce progesterone, which in turn
inhibits the hypothalamus and APG thus stopping the estrogen LH positive feedback loop
(Clelland and Yeng, 2009; Nagahama et al., 2008; Zhang et al., 2015). The idea of feedback
loops and the delicate maintenance of homeostasis will play a central role in this paper.
At the molecular level, FSH and LH are glycoprotein polypeptide hormones. They
share a common α subunit while maintaining distinct β subunits. FSH is primarily
responsible for promoting early gonadal development and growth, stimulating follicular
growth and estrogen production by binding its cognate FSH receptor (FSHR) (Kwok et al.,





2005; Mazon et al., 2011). The FSHR is expressed in both theca and granulosa cells.
Meanwhile LH regulates the late stages of gametogenesis and final gamete maturation and
release, stimulating androgen production by theca cells which acts as a substrate for
estrogen production in granulosa cells. The LH receptor (LHR) is expressed on granulosa
cells only. However, the FSHR has the ability to bind both FSH and LH (Kwok, 2005; So
et al., 2005).
FSHR and LHR are typical G protein-coupled receptors (GPCRs) containing the
canonical transmembrane region consisting of 7 transmembrane domains (Kwok, 2005;
So, 2005). They detect extracellular signals and direct intracellular signal transduction
ultimately activating a cellular response. Because they are gonadotropin receptors, and the
most important regulators of gonadal development and function, FSHR and LHR
expression is in turn under tight control by various endocrine and paracrine factors in the
gonads (Clelland, 2009; Kwok, 2005). We will return to the regulation of FSH and LH
shortly but first attention must be paid to the mechanism by which the gonadotropins exert
their cellular affects while being unable to cross the plasma membrane themselves and
directly affect the expression of the genes involved in ovulation.
The Cyclic-AMP (cAMP) Secondary Messenger System
A large number of endocrine and neuronal functions are mediated by the cyclic
AMP (cAMP) dependent pathway (Sassone-Corsi et al., 1998). FSH and LH bind their
transmembrane receptors which are coupled to stimulatory G proteins that activate
adenylyl cyclase generating high levels of intracellular cAMP (Kwok, 2005). cAMP is thus
critically important to gonadotropin signaling. Indeed, it has been shown that following LH
stimulation, an increase in intracellular cAMP produces profound changes in expression of



those genes required for switching the pattern of steroidogenic hormone production,
withdrawal from the cell cycle, and altering the structure of the follicle wall to allow
ovulation (Park et al., 2003). Similarly, FSH induces estrogen biosynthesis through the
cAMP-dependent pathway to regulate the expression of the CYP19A1 gene which will be
discussed in greater detail below (Parakh et al., 2006).
cAMP is the prototypical example of a second messenger: intracellular molecules
which mediate the effects of first messengers. A typical second messenger system consists
of five parts: first messenger, signal transducer, primary effector, second messenger, and
secondary effector. The first messenger is typically a neurotransmitter or hormone, which
being unable to cross the phospholipid bilayer, must rely on a transmembrane signal
transducer to generate an intracellular response. The signal transducer takes the form of a
transmembrane receptor that upon activation by the binding of its ligand undergoes a
conformational change causing it to activate a nearby membrane bound protein known as
the primary effector. The primary effector is an enzyme which in turn catalyzes the
synthesis of a signal molecule that can diffuse into the cell. This signal molecule is known
as a second messenger. The second messenger diffuses into the cell and activates a
secondary effector protein, typically another enzyme, whose downstream effect will
depend upon the specific secondary messenger system in question, but is usually the
activation or repression of target genes (Willoughby and Cooper, 2007).
In the case of FSH and LH, they mediate their effects through the cAMP secondary
messenger system (Mukherjee, 1998). In this system the first messenger (the hormones:
FSH and LH) interacts with their particular signal transducer (the GPCRs: FSHR and LHR)
to stimulate the primary effector (the enzyme: adenylyl cyclase). Adenylyl cyclase then



catalyzes the conversion of ATP into the second messenger cyclic-AMP. cAMP then works
on the secondary effector enzyme, protein kinase A (PKA) to produce final downstream
effects (Sassone-Corsi, 1998; Willoughby and Cooper, 2007). Specifically, the rise in
intracellular cAMP concentration brought on by activation of adenylyl cyclase results in
cAMP binding the regulatory subunits of PKA causing a dissociation between the
regulatory and catalytic subunits allowing the active catalytic subunits to translocate into
the nuclease and there phosphorylate substrate proteins (Sands et al., 2008; Sassone-Corsi,
1998). PKA translocates into the nucleus where it phosphorylates and thereby stimulates
transcriptional activators capable of binding to cAMP response elements (CRE) which
induce transcription from the promoters of cAMP responsive genes. A final step in the
cAMP signaling cascade is the activation of the cAMP responsive transcription factors
such as CREB and CREM, which in turn transactivate the transcriptional expression of
cAMP responsive target genes (Molina et al., 1993). The critical role of cAMP-responsive
transcription factors cannot be overstated and the next section of this paper will be devoted
to an explanation of these transcription factors.
The cAMP Response Family: CREB CREM ICER
To fully explain how the cAMP system mediates gene expression we must
understand the family of transcription factors through which it acts and the genes which
encode these transcription factors. By analyzing the regulatory sequences of genes known
to be affected by the cAMP pathway, promoter elements were identified where intracellular
cAMP mediated a transcriptional response. This element became known as the cAMP
response element (CRE). The consensus CRE site is an 8 bp palindromic sequence 5’TGACGTCA-3’ (Molina, 1993; Sands, 2008; Sassone-Corsi, 1988).



Following the discovery of the CRE, proteins were elucidated which showed high
affinity for binding the CRE. These proteins became known as CRE-binding (CREB)
proteins. All CREB proteins belong to the bZIP or basic-region leucine zipper transcription
factor family. CREB proteins are coded for by the CREB gene. Structural and functional
analysis of CREB proteins lead to the identification of the closely related cAMP response
element modulator (CREM) protein, encoded by the CREM gene (Sassone-Corsi, 1998).
CREM is a multiexonic gene that encodes a family of activators and repressors of cAMPinducible transcription via alternative exon splicing (Molina, 1993). CREB, CREM, and
ATF-1 make up the CREB subfamily of bZIP transcription factors. Like all bZIP
transcription factors CREB family members contain the C-terminal basic domain, also
known as the DNA-binding domain which mediates DNA binding by the transcription
factors, and the leucine zipper domain that allows for dimerization. Because of their highly
similar bZIP domains the CREB family can homo- and heterodimerize allowing the
different activators and repressors to bind each other and mediate their effects. Another
effect of their high bZIP domain homology is that all CREB family members recognize
and bind the CRE. In addition to the DNA-binding domain, CREB family members also
share a transactivation domains known as the phosphorylation (P-) box or kinase inducible
domain (KID) (Meyer et al., 1993; Lonze et al., 2002). It is here where the cAMPdependent PKA phosphorylates a serine residue within the P-box activating the proteins,
which subsequently modulate CRE-mediated gene expression. Through a complex system
of differential splicing, alternative promoter usage and autoregulation, cAMP signaling
enhances the expression of CREB and CREM isoforms with differing transactivation and
repression properties, that in turn due to their high homology of bZIP domains can homo-



and heterodimerize allowing for intricate interactions and myriad downstream effects
(Molina, 1993; Sassone-Corsi, 1998). A diagram of the structures of the CREB and CREM
genes, to better visualize these elements, taken from a 2000 paper by Bodor et al., is below.

Figure 11 Fig. 1. Diagrammatic structures of the CREB and CREM genes showing
repressor ICER isoforms generated by alternative start sites of transcription and translation
(Bodor et al., 2000).
Perhaps the most interesting of these isoforms is the inducible cAMP early
repressor (ICER). ICER is the product of the alternative utilization of an internal promoter,
P2, of the CREM gene which produces a truncated protein consisting solely of the DNA
binding domain of CREM. Because the ICER open reading frame only encodes the leucine
zipper and basic regions of the CREM gene product, it has the unique ability to not only
bind CRE but also to heterodimerize with other CREM proteins and with CREB. It is this
ability which allows ICER to be a dominant negative repressor of the cAMP system. Also,
unlike the other CREM isoforms ICER-mediated repression is based only on the
stoichiometric concentration of ICER in the cell. This is because ICER lacks the P-box and
thus cannot be phosphorylated by PKA. The ICER alternative promoter P2 of CREM



contains 2 pairs of cAMP autoregulatory response elements (CARE) which differ slightly
from the consensus CRE. It is through these slightly altered CARE, that ICER is
transcriptionally induced by CREB. Furthermore, ICER negatively autoregulates its own
transcription in response to high ICER levels. Following ICER induction by CREB in
response to cAMP, ICER competes with and represses CREB-mediated gene transcription,
before finally repressing its own transcription through the CARE of the P2 of the CREM
gene as shown in Fig. 12. Again, this repression is based solely on ICER concentrations
and not the degree of phosphorylation. Because the cAMP second messenger system is an
important signal transduction pathway in a wide variety of cells, it makes sense that the
expression of cAMP responsive genes also exists under a tight system of control involving
competing activation and repression (Molina, 1993; Stehle et al., 1993).

Figure 12 Figure 9. The Role of ICER in the Regulation of Gene Expression by cAMP
(Molina, 1993).
The Inhibin-Activin-Follistatin System





Returning to the idea of fertility, ovulation is a very energy intensive investment in
an organism, and as such it is under strict regulatory control. Thus far an overview of the
endocrine system of regulation at the organismal level involving the feedback mechanisms
of the hormones, FSH and LH, and the steroids, estrogen and testosterone, as well as the
intracellular cAMP second messenger system and the roles of CREM, CREB and ICER
has been undertaken. A further level of regulation is maintained through the inhibinactivin-follistatin system.
Activin and inhibin are growth factors belonging to the transforming growth factor
beta (TGFβ) superfamily. Similar to FSH and LH the idea of shared and differing subunits
come into play here. Activin is a homo- or heterodimer consisting of two β subunits: βA
and βB. The dimerization system of the β subunits gives rise to three forms of activin:
activin A (βAβA), activin B (βBβB), and activin AB (βAβB) (Lin et al., 2003; Wang et
al., 2004). Inhibin is a heterodimer consisting of a β subunit and a specific α subunit.
Activin acts by binding to a specific type II receptor which then recruits a type I receptor
to allow for intracellular signaling. Inhibin does not have its own signaling receptor and
instead competes with activin for its type II receptor (Poon et al., 2009). Follistatin,
meanwhile, is a single-chain glycosylated protein that acts as a binding protein of activin
and neutralizes its bioactivity (Popovics et al., 2011; Wun Li et al., 2013). Activin has a
stimulatory effect on FSH release, while inhibin has an inhibitory effect on FSH. Neither
has any effect on LH release in the pituitary. Follistatin is found to be expressed primarily
in the ovarian follicles (Lin, 2003; Poon, 2009; Popovics, 2011; Wang, 2004; Wun Li,
2013).





Activin stimulates follicular growth and granulosa cell proliferation, and also
stimulates the expression of FSHR and FSH-induced LHR in granulosa cells.
Gonadotropins in turn stimulate activin βA and follistatin expression but suppress activin
βB expression (Lin, 2003). The stimulation of activin βA and follistatin by human
chorionic gonadotropin (hCG) is mediated by the cAMP-PKA pathway in cultured
zebrafish follicle cells, whereas hCG inhibition of activin βB expression is signaled
through a cAMP-dependent but PKA-independent pathway (Wang, 2004). The
mechanisms of regulation of oogenesis and folliculogenesis are complex and involve
significant crosstalk between different signaling pathways intracellularly, and different
paracrine and endocrine systems on the organismal level. As mentioned earlier, FSH
stimulates estrogen biosynthesis, and LH and estrogen form a positive feedback loop
stimulating ovulation, while estrogen in turn inhibits GnRH production in the
hypothalamus, all the while inhibin inhibits activin, which itself positively stimulates
GnRH producing cells, and inhibin and activin themselves finally exert opposing effects
on FSH completing the Gordian knot or serpent eating its tail regulatory framework of
ovulation. Because no discussion of female reproduction is complete without mentioning
estrogen we will turn briefly to the biosynthesis of estrogen next.
Cyp19A1 An Ovarian Specific Promoter
The goal of many experiments is to measure gene expression in a tissue specific
manner. Most genes are under the control of promoters which respond to certain
transcription factors and whose activity are mediated and regulated through external
factors. Aromatase P450 is an enzyme responsible for the final step of estrogen
biosynthesis from androgens. It catalyzes the aromatization of C19 steroids into C18





estrogens (Kazeto et al., 2001). The major site of estrogen biosynthesis is the ovary
(Michael et al., 1997). Aromatase P450 gene expression in the ovary is regulated by FSH
through the cAMP second messenger system. FSH causes an increase of intracellular
cAMP, which through the cAMP pathway stimulates the expression of the CYP19 gene
encoding aromatase P450 (Kazeto, 2001; Michael, 1997).
Zebrafish have two cyp19 genes: cyp19a which is predominantly expressed in
follicular cells lining the oocytes within the ovary, and cyp19b which is expressed in the
brain (Tanaka et al., 1995). Sequence analysis of the cyp19a gene identified many
regulatory elements within its 2.5kb promoter region, including a TATA box, a
steroidogenic factor-1 recognition site, estrogen receptor half site, androgen receptor half
site as well as a CRE- like sequence (CLS) 5’-TGCACGTCA-3’ which has been found to
be critical for cAMP induction of aromatase in humans (Michael, 1997). Additional
research has shown that cyp19a can be induced by estrogens, while it is inhibited by
androgens (Tong and Chung, 2003). In zebrafish cyp19a1 is an ovarian specific gene. For
this reason, the cyp19a1 promoter region can be utilized in a vector to drive the expression
of genes in an ovary specific manner. Thus we chose to place transgenic ICER under the
control of the zebrafish cyp19a1 promoter in this study.
Zebrafish as a Model Organism
Zebrafish are rapidly becoming one of the most widely used model organisms in
scientific research. The zebrafish is a tropical freshwater fish, that before becoming an
animal model, was a popular aquarium fish. Zebrafish are inexpensive to maintain and
relatively easy to care for. Their genome has been sequenced and they show a high degree
of genetic identity to humans and higher vertebrates. Zebrafish have quickly become





popular organisms of choice in research into evolution, genetics, neurobiology,
development, and reproduction.
Reproductive science is an important branch of medical research and infertility as
mentioned previously is a persistent and devastating ailment globally. Zebrafish are ideal
model organisms for reproductive studies because of their high homology with humans at
the genomic and transcriptomic level (Howe et al., 2013; Zon and Peterson, 2005). They
demonstrate a large degree of similarity within the neuroendocrine system of reproductive
regulation (Segner, 2009; Ying Hoo et al., 2016). Additionally, zebrafish have a short
generation time reaching sexual maturity within 3 months. Female zebrafish have bilateral
ovaries which are structurally and functionally quite similar to those of humans. There are
four stages of ovarian development in zebrafish: the primary oocyte stage, cortical-alveolar
stage, vitellogenic stage, and finally the maturation stage. Females are morning breeders
capable of spawning from 50 to well over 200 eggs in a spawning session. Zebrafish eggs
are translucent and typically around 0.7mm in diameter. They undergo rapid embryonic
development with precursors for major organs visible within 24 hours of fertilization, and
most major organs reaching full development within 72 hours post fertilization (Segner,
2009; Ying Hoo, 2016). Their transparency and external development lend large
advantages when compared with rodent models. For this reason, the use of fluorescent
markers to study gene expression during embryonic development of zebrafish is very
popular among researchers. The high fecundity, large brood size, small embryo size and
rapid development of zebrafish lend themselves well to high throughput screening.
The close evolutionary relationship of zebrafish to higher vertebrates makes the
zebrafish well suited to genomic investigation (Howe, 2013; Thisse et al., 2004). Just as in





mammals, the zebrafish reproductive system is under tight control by the three hormonal
feedback control axes: the hypothalamic-pituitary-gonadal (HPG) axis, the hypothalamicpituitary-adrenal (HPA) axis, and the hypothalamic-pituitary-thyroid (HPT) axis. In fish
and other oviparous organisms, the HPG axis is sometimes referred to as the HPG-liver
axis because the liver synthesizes the protein vitellogenin (VTG), an egg yolk precursor
protein, that is the precursor of the lipoproteins and phosphoproteins of which the majority
of the protein content of the yolk is comprised. VTG is synthesized under the control of
estrogens produced by the ovaries (Segner, 2009; Ying Hoo, 2016). Zebrafish have
asynchronous ovaries, that contain follicles at all stages of development. Females will
spawn year round under laboratory conditions. The zebrafish follicle contains a large
oocyte surrounded by the zona radiata or vitelline envelope. The follicular layer consists
of an inner layer of granulosa cells separated from an outer layer of theca cells (Segner,
2009; Ying Hoo, 2016). Follicular development is separated into stages based on the size
of the follicle: primary growth stage (PG), previtellogenic/ cortical alveolar stage (PV),
early vitellogenic stage (EV), midvitellogenic stage (MV), late vitellogenic stage (LV), and
full grown stage (FG) (Clelland and Peng, 2009; Koc et al., 2006; Selman et al., 1993).
Because of high degree of functional similarity of hormonal regulation between the
zebrafish reproductive system and humans they are a popular organism of choice in
endocrine studies. Specifically, in chemical screenings to test whether compounds are
endocrine-disruptive. Due to their ease of maintenance, large degree of evolutionary
similarity to higher vertebrates, short maturation time, rapid development, high fecundity,
and fully sequenced genome zebrafish are a phenomenal model organism well suited to
scientific research. (Segner, 2009; Ying Hoo, 2016).



 

The Tol2 Trasngenesis System
Transgenesis involves the introduction of an exogenous gene into a living organism
so that the organism will express the foreign gene and pass it on to its offspring. There are
many methods to produce transgenic organisms and all carry unique advantages and
disadvantages. Transposable elements (TE) or transposons are DNA sequence which can
change their position within the genome. Generally divided into two classes:
retrotransposons which function via reverse transcriptase and DNA transposons which
encode the protein transposase, transposons were first discovered in maize (McClintock,
1950). Because of their ability to move within a genome, transposons can introduce or
reverse mutations, alter the genotype and change the genome size. For this reason, many
organisms have mechanisms to inhibit transposon activity. RNA interference is a common
method of inhibiting transposon activity. Evolution also often deactivates transposons
rendering them introns. Thus most vertebrate genomes contain large numbers of
transposons which are naturally inactive. One exception is the Japanese rice fish (Oryzias
latipes) also known as the medaka.
The medaka belongs to the class Actinopterygii of ray-finned fish similar to the
zebrafish. In medaka fish the Tol2 transposable element was found to be autonomously
active. Tol2 is an autonomous transposon about 4.7 kb in length that encodes a gene
consisting of four exons which encodes for a fully functional 649 amino acid long
transposase protein. Tol2 integrates via a cut and paste mechanism and does not modify
the target site except for the introduction of an 8 bp duplication (Kawakami, 2007). Most
fascinating of all Tol2 transposase can catalyze the transposition of a construct with the
transposase coding region deleted and replaced by an exogenous DNA insert. A transposon



 

construct must simply contain two minimal cis regulatory sequences consisting of 200 bp
and 150 bp of DNA from the left and right ends of Tol2, respectively, to be sufficient for
transposition. These sequences contain 12 bp terminal inverted repeats and subterminal
regions necessary for transposition (Kawakami, 2007). Any foreign DNA can be cloned
between these sequences and inserted into an organism’s genome when microinjected with
an mRNA encoding the accompanying Tol2 transposase. This allows for a very flexible
and easy to use transgenesis method. Once transposase activity has ended the excised DNA
is now stably integrated into the genome (Kawakami, 2007; Kwan et al., 2007).
The Tol2 system has revolutionized the generation of transgenic organisms and is
widely used in zebrafish research. Embryos can be microinjected with the Tol2 transposase
mRNA and a Tol2 vector containing a gene of interest. About 50% to 70% of injected fish
will produce transgenic offspring, at frequencies between 3% and 100% (Kawakami,
2007). The generation of stable transgenic lines is thus possible and within the ability of
any researcher. The Tol2 system is particularly well suited for the study of genes with tissue
specific expression. Simply place the gene of interest under the control of a tissue specific
promoter and tissue specific expression can be easily quantified.
Goals of this Study
The cAMP system rears its head again and again as you investigate the intracellular
mechanisms, by which the regulation of the HPG axis, are mediated. It might seem odd or
even counterintuitive that one single factor can play such a crucial role in so many diverse
yet intimately intertwined processes. It may even engender disbelief that the simple
elevation of cAMP levels can allow such finely tuned responses. After all, once cAMP
levels are elevated wouldn’t they diffuse throughout the cell and render it refractory to any



 

further stimulation? While there is some evidence that ICER, through its interaction with
cAMP in a concentration specific manner, plays a role in desensitizing and resensitizing
cells to cAMP induction, the bigger picture is considerably more complex. But just as at
the heart of every atom are protons, neutrons, and electrons, the cAMP system is composed
of parts and ICER is a fundamental and unique component of the system. Thus we must
first understand ICER to understand any of the higher degrees of control of cAMPdependent pathways in the ovary.
The goals of this research are two-fold. First to determine whether ICER is
expressed in the zebrafish ovary by stage. If this turns out to be the case, then we will move
on to our second goal: the generation of a transgenic zebrafish expressing ICER under the
control of an ovarian promoter. Because ICER is such an important part of the cAMP
second messenger system which in turn is a critical element of neuroendocrine regulation,
we wish to ultimately examine the effects of the overexpression of ICER in zebrafish
ovaries. Previous research, in mouse models, has demonstrated that female mice
overexpressing ICER are hyperovulatory. A two-fold increase in ovulation rate was
observed in the immature transgenic mice compared to the wild type in response to
exogenous gonadotropin treatment. Additionally, mature cycling transgenic mice display
a significantly enhanced ovulation rate compared to the wild-type (Muñiz). Many studies
have also been undertaken examining the role of ICER in spermatogenesis but the literature
on the role of ICER in folliculogenesis and oogenesis is significantly sparser. Given the
utility of the zebrafish as a model organism for reproduction we believe an investigation of
ICER in zebrafish ovulation is an important avenue of research. The implications of this
research can have wide ranging effects from human fertility, where gonadotropins and



 

estrogen antagonists are frequently used to enhance ovarian activity prior to IVF
treatments, to aquaculture, where the growing human population and demand for fish is
placing significant strains on wild populations and farmed fish alike.



 

METHODS AND MATERIALS
Zebrafish Maintenance
Zebrafish were maintained in house at a water temperature between 24-30ºC, at a pH
between 7.0 and 8.0, and a photoperiod of 10-hour light and 14-hour dark to encourage
breeding.
SDS-PAGE
The Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis SDS/PAGE was
performed according to the protocol set forth by the Mini-PROTEAN® Tetra Cell
manual. Pre-made 4-20% polyacrylamide gels were utilized, and loaded with 20 μl of
sample per well. Following loading the gels were placed in the electrophoresis gasket and
tank and filled with buffer solution. Electrophoresis was performed for 35 minutes at a
voltage of 200v.
Polymerase Chain Reaction (PCR) to Introduce NcoI Site
Polymerase Chain Reaction was performed using the Promege PCR Master Mix. Primers
were designed and ordered from Eurofins Genomics. Left primer 1 had the sequence 5’TGAGCTCGGATCCATGGACCCC-3’. Right primer 1 had the sequence 5’AAGTGAAGGCCCATGAGGC-3’. Left primer 2 had the sequence 5’TGAGCTCGGATCCATGGACC-3’. Right primer 2 had the sequence 5’CCCATGAGGCCAGTTAATTAAGA-3’.
Following the Promega Protocol samples were prepared at the following volumes: 25μl
of PCR master mix, 20μl of nuclease-free water, 2μl of template DNA, 1.5μl each of the
left and right primers for total of 3μl for a total of 50μl. Amplification was then
performed according to the protocol. An initial denaturation step of 2-minutes at 95ºC,





followed by 30 cycles with 95ºC denaturation for 30 seconds, annealing starting at 5ºC
below the melting temp of the primers which was then increased by 1 ºC until the
annealing temperature was reached, extension at 72ºC for 1 minute. Cycling was
followed by a final extension of 5 minutes at 72ºC. Then the reaction was held at 4ºC.
Site-Directed Mutagenesis (SDM) to Introduce NcoI Site
Site-Directed Mutagenesis was performed using the Agilent Technologies QuikChange
Lightning Site-Directed Mutagenesis kit. Primers were designed and ordered from
Eurofin Genomics. The first primer t393g_A had the sequence 5’CACGTCGTAGGGGTCCATGGATCCGAGCT-3’. The second primer t393g_B had the
sequence 5’-AGCTCGGATCCATGGACCCCTACGACGTG-3’.
To set up the PCR reaction 2.5μl of 10X buffer, 17μl of nuclease-free water, 1.5μl of
template DNA, 1μl each of 2 primers for total of 2μl, 1μl of dNTP mix and 1μl of
polymerase was combined in each sample tube for a total of 20μl. PCR amplification was
performed according to the QuikChange protocol as follows:

This was followed by a DpnI restriction digest to digest parental dsDNA before
proceeding to a miniprep and transformation of the PCR product into competent E. coli
cells.





Restriction Digests
The following restriction enzymes were utilized in this study according to the
manufacturer’s specifications:
KpnI cuts 5’…GGTAC/C…3’
NcoI cuts 5’…C/CATGG…3’
For the NcoI/KpnI digestion of the SDM product the volumes used were as follows:
• 16μl DNA from SDM miniprep colonies
• 2μl 10X enzyme buffer
• 1μl NcoI
• 1μl Kpn1
The reaction was allowed to proceed for 10 minutes at 37ºC incubation.
For the NcoI/KpnI digestion of the PCR product the volumes used were as follows:
• 50μl DNA from PCR reaction
• 5μl 10X enzyme buffer
• 2.5μl NcoI
• 2.5μl Kpn1
The reaction was allowed to proceed for 15 minutes at 37ºC incubation.
For the NcoI/KpnI digestion of the pTol plasmid vector the volumes used were as
follows:
• 16μl DNA pTol plasmid
• 2μl 10X enzyme buffer
• 1μl NcoI




• 1μl Kpn1
The reaction was allowed to proceed for 15 minutes at 37ºC incubation.
Successful restriction digests were confirmed utilizing gel electrophoresis.
Ligation
Ligation was performed using the Promega LigaFast Rapid DNA Ligation System
according to the manufacturer’s protocol.
For the ligation of the SDM product the volumes used were as follows:
• 0.8μl vector DNA
• 0.3μl insert DNA
• 5μl 2X Rapid Ligation Buffer
• 3μl T4 DNA Ligase
• 0.9μl Nuclease-Free Water
• For a total volume of 10μl.
For the ligation of the PCR product the volumes used were as follows:
• 2μl vector DNA
• 1μl insert DNA
• 5μl 2X Rapid Ligation Buffer
• 3μl T4 DNA Ligase
• 0μl Nuclease-Free Water
• For a total volume of 10μl.
The reactions were incubated at room temperature for 5 minutes.





RESULTS
ICER Protein Expression Peaks During Early Folliculogenesis
ICER protein expression is seen across all stages of folliculogenesis. However,
there are significant changes in protein expression in a stage-dependent manner. As shown
in Fig.1A ICER expression is heaviest at the PV stage of folliculogenesis. The strongest
banding supports a peak in ICER expression at this stage. In the EV and MV stages ICER
expression is still detectable at significant levels. There is a diminishing expression at the
LV stage and minimal expression at PG and FG stages.
In Fig.1B we show ubiquitous ICER expression across tissue types, with
predominant expression in the testis as expected based on the heavy previous research
which has focused on the role of ICER in spermatogenesis. We also observed significantly
measurable expression in the ovaries in support of further investigation into the function
of ICER in ovulation. Fig.1C shows ICER ovarian expression across stages of
folliculogenesis. In confirmation of the earlier data, ICER again shows strong expression
at the PV, EV, and MV stages, however in this case we observed equal expression at PV
and EV, with a reduction at MV. Furthermore, there was again diminished but perceptible
expression at the PG, and LV stages. Notably there is no ICER expression at the FG stage.
Fig.4D is data from a previous experiment showing the expected sizes of ICER as well as
CREM isoforms (Molina et al. 1993). ICERγ, the focus of this study, is determined to be a
protein somewhere in the range of 18-19.5 kDa. Our observations of ICER protein
expression consistently supports this range.





ICER RNA Expression Shows Two Peaks at PV and LV Stages of Folliculogenesis
In order to quantify ICER RNA expression, semi-quantitative PCR analysis was
undertaken. ICER RNA is expressed across all stages of folliculogenesis. In keeping with
the protein expression data, the RNA expression is lowest at the PG and FG stages.
However, in contrast to the protein expression data, RNA expression displays two peaks
first at the PV stage and second at the LV stage. The LV stage actually appears to be the
most significant stage of ICER RNA expression in the follicle. ICER mRNA expression
shows an initial peak at the PV stage followed by a decline in the EV stage and a further
decline in the MV stage. Then ICER mRNA expression surges at the LV stage before again
declining at FG. Taken in context the cyclical stage-dependent expression pattern of ICER
mRNA underscores the nature of its regulation and its negative autoregulation in response
to cAMP levels. Having confirmed the expression of ICER in the ovaries is stagedependent at both the RNA and protein levels, the construction of an ICER overexpressing
plasmid vector under the control of an ovarian promoter is a next logical step in the further
elucidation of the role of ICER in ovulation.
Introduction of an NcoI Site into ICER
Having confirmed that ICER is indeed expressed in the zebrafish ovary we turned
our attention to the design of an ovarian specific plasmid vector for the overexpression of
ICER in the zebrafish ovary. In order to insert our ICER construct in the plasmid vector it
was first necessary to remove EGFP from the previously used and demonstrated construct.
To do so we utilized two restriction sites NcoI and KpnI. This was a relatively
straightforward digestion confirmed in Fig.5 lanes 5-8. Lanes 5-8 contain the pminTol2
plasmid vector (5863 bp) containing 1.8kb 5’UTR of cyp19a1 as well as EGFP which runs



 

near the 750 band in keeping with its size of 768 bp. The ICER construct itself did not
contain an NcoI site and in order to facilitate its insertion into pminTol2 we decided to
introduce a novel NcoI site into ICER. We chose two methods for the introduction of this
mutation into ICER. First we designed PCR primers with the NcoI site incorporated and
utilized these primers to amplify ICER DNA containing our mutation. This was confirmed
following a restriction digest with KpnI and NcoI and the results are shown in Fig.5.
Lanes 1 and 2 contain primer set 1 and 2, respectively, for zebrafish ICER wild type
(wt). The ICER band appears just below 400 in keeping with its predicted size of 368 bp
following digestion. Lanes 3 and 4 contain primer set 1 and 2, respectively, for zebrafish
ICER knockout (ko) again with a band near the 400 mark. A second method of introducing
the NcoI site mutation was undertaken to ensure the generation of mutants. In the second
route we utilized site-directed mutagenesis to introduce the necessary T to G mutation
(5’…CCATGT…3’ into 5’…CCATGG…3’). SDM was performed and confirmed with
SDS-PAGE. As shown in Fig. 6 all seven clones were positive for the mutation.
Insertion of Mutated ICER into the pmintol2 Plasmid
Finally, our amplified ICER products were digested with KpnI and NcoI and
inserted into the pminTol2 cyp19a1prom plasmid via ligation. In Fig. 7 lanes 1, 5, 8-10 all
show positive zfICERγ product running near the 400 marker. Lanes 2 and 7 show the EGFP
of the original plasmid running near the 750 marker. Lane 3 contains no genetic material
and lane 4 contains both ICER and EGFP the likely result of pipette error by the user
resulting in two samples being placed in the well for lane 4. Material from lanes 1, 5, 8, 9,
and 10 were removed and sequenced and the product was confirmed to be zfICERγ.
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Figure 1 ICER Protein Expression
A. ICER and CREM expression by stage. CREM expression peaks at the PG stage. ICER
expression on the other hand peaks at PV before showing a significant decline through
the EV, MV, and LV stages with faint signal at the FG stage. B. ICER expression by
tissue. ICER is ubiquitously expressed across tissue types with significant expression in
the testis. ICER expression is also detectable in the ovaries. C. ICER and CREM
expression by stage. Again CREM expression peaks at the PG stage. ICER expression on
the other hand peaks at PV before showing a significant decline through the EV, MV, and
LV stages with faint signal at the FG stage. D. Data from Molina, 1993 demonstrating
expected ICER and CREM sizes. Depending on the specific ICER isoform the expected
ICER product size is 18 kDa or 19.5 kDa. CREM isoforms will generate an expected
product of 35 kDa or 45 kDa.



 

 
       













  













Figure 2 ICER RNA Expression
ICER RNA expression based on semi-quantitative PCR. Results show faint but detectable
ICER RNA expression at the PG stage. ICER RNA expression increases in the PV stage
before showing a slight decline in signal intensity at the EV and MV stages. A second
peak in intensity is seen at the LV stage before another decline and a faint but detectable
signal at the FG stage.



 



Figure 3 ICER sequence prior to insertion of novel NcoI site.



 

Figure 4 Original pminTol2 cyp19A1prom plasmid containing EGFP





Figure 5 Digestion with NcoI and KpnI
Lanes 1 and 2 contain primer set 1 and 2, respectively, for zebrafish ICER wild type (wt).
The ICER band appears just below 400 in keeping with its predicted size of 368 bp
following digestion. Lanes 3 and 4 contain primer set 1 and 2, respectively, for zebrafish
ICER knockout (ko). Again, the ICER band appears just below 400 in keeping with its
predicted size of 368 bp following digestion. Lanes 5-8 contain the pminTol2 plasmid
vector (5863 bp) containing 1.8kb 5’UTR of cyp19a1 as well as EGFP which runs near
the 750 band in keeping with its size of 768 bp.





Figure 6 Wild Type Site-Directed Mutagenesis
SDM of wt zfICERγ to introduce the NcoI restriction site followed by digestion with
NcoI and KpnI. The detection of two bands shows successful restriction digest
confirming that all seven clones in lanes 1-7 are positive for the introduced mutation.





Figure 7 NcoI KpnI digestion after ligation wt zfICER pminTol2 (1.8kb 5’UTR
cyp19A1).
Lanes 1, 5, 8-10 all show positive zfICERγ product running near the 400 marker. Lanes 2
and 7 show the EGFP of the original plasmid running near the 750 marker. Lane 3
contains no genetic material and lane 4 contains both ICER and EGFP the likely result of
pipette error by the user resulting in two samples being placed in the well for lane 4.
Expected size: ICER-368 bp, EGFP-768 bp, pminTol2-5863 bp
Material from lanes 1, 5, 8, 9, and 10 were removed and sequenced to confirm the
product was in fact ICER.





Figure 8 pminTol2 cyp19A1prom HAzfICERγ wt
The final plasmid construct containing zfICERγ downstream of the cyp19a1 5’UTR.





DISCUSSION
The generation of stable transgenic zebrafish expressing ICER under the control of
the ovarian cyp19a1 promoter is an important first step in elucidating the pivotal and
important role that ICER plays in reproduction. Here we demonstrate the construction of a
Tol2 plasmid vector containing the ICER gene downstream of the 1.8 kb 5’UTR of
cyp19a1, an ovarian specific aromatase gene. First it was necessary to prove that ICER was
indeed expressed in the ovaries in vivo. ICER was shown to be ubiquitously expressed
across multiple tissue types with the highest expression in the testis followed by the ovaries.
Protein and RNA expression were then measured in the ovaries specifically. ICER protein
expression peaked at the PV stage and declined through the EV, MV, and LV stages with
a sharp decline at the FG stage. ICER RNA expression showed two peaks at the PV and
LV stages as measured by semi-quantitative PCR. Having confirmed that ICER is
expressed in the ovary and that its expression is stage dependent we moved on to the
generation of an ICER Tol2 vector for insertion into the zebra fish genome.
Two methods were used to generate an ICER construct containing flanking NcoI
and KpnI restriction sites. In order to introduce the NcoI restriction site it was necessary to
change 5’…CCATGT…3’ into 5’…CCATGG…3’ within the ICER construct. We utilized
PCR to amplify a mutated ICER DNA sequence by designing primers intended to insert a
G in place of a T thereby introducing a new NcoI restriction site into our construct. This
proved successful and was confirmed via restriction digestion with KpnI and NcoI
followed by gel electrophoresis. Additionally, site-directed mutagenesis was utilized in a
similar manner introducing the T to G mutation and confirmed by restriction digest and gel
electrophoresis. Finally, a pTol2 vector was created by first removing EGFP from a



 

previously designed vector which expressed EGFP under the control of the cyp19a1
promoter region. Our new ICER construct was then inserted into the pminTol2 cyp19a1
promoter vector by digestion with NcoI and KpnI followed by ligation to create a new
vector containing ICER. Again gel electrophoresis confirmed the existence of an ICER
sized product within the pTol2 vector.
To confirm that this product was indeed ICER, material was excised from lanes 1,
5, 8, 9, and 10 and sent to be sequenced. Sequencing data did then confirm that this product
was indeed ICER proving the successful insertion of ICERγ into the pminTol2
cyp19a1prom vector. This vector can be utilized in future studies, with the Tol2 system, to
generate a line of transgenic zebra fish that can be induced with gonadotropin stimulation
to overexpress ICER within the ovaries.

Table 1 Expression patterns of various growth factors, receptors, and steroidogenic
enzymes during zebrafish follicle development (Clelland, 2009).



 

As can be seen in the table above from a 2009 review of the expression patterns of
various growth factors, receptors, and steroidogenic enzymes during folliculogenesis, there
are an extensive number of paracrine/autocrine factors produced within the ovary that
interact with the gonadotropins to modulate follicle development and oocyte maturation
(Clelland, 2009). Some of these have been mentioned previously while others are beyond
the scope of this research. Furthermore, this serves to highlight how important ovulation is
to an organism, and due to its importance and the investment on the part of the organism
to maintain the system, just how tightly controlled all the events which lead to the final
production of a mature oocyte are. The cAMP second messenger system is critically
involved in the endocrine system and cAMP itself plays an essential role in follicular
development, atresia, and luteinization in the ovary (Wang et al., 2007). The critical role
of cAMP in mediating FSH and LH signaling, as well as its involvement in the inhibinactivin-follistatin system of endocrine regulation, underscore the importance of
understanding the manner in which the cAMP system itself if regulated to further clarify
the intricate feedback loops and regulatory mechanisms of the ovarian cycle. Temporally
restricted gene expression is vital to many diverse biological processes. And it is
abundantly clear that the precise timing and synchronization of the pattern of gene
expression and ovulation, is integral to the maintenance of fertility and that the result of
any disruption of this highly coordinated system is infertility. By understanding the
mechanisms of the regulation of the system which itself underlies the regulation of the
endocrine system we can begin to shed new light on the complex mysteries of fertility, and
the pathogenic factors causing infertility.



 

There is a final part of the cAMP second messenger system which hasn’t been
discussed yet. Earlier it was mentioned that it almost defies belief that cAMP
concentrations can have such myriad effects within a cell once cAMP concentrations begin
to ubiquitously rise intracellularly. It was long believed that cAMP signal transduction
depended on random collisions between signaling components within the cell (Martin and
Cooper, 2006). However, starting in the late 1980’s our understanding of the cAMP system
drastically changed. As mentioned previously a fundamental step of the cAMP system is
the synthesis of cAMP itself by the activity of adenylyl cyclase (AC). Long viewed as a
single entity that was itself regulated by hormones in either a stimulatory or inhibitory
manner through the actions of stimulatory or inhibitory G proteins of the GPCR, it has
since been discovered that there actually exist 10 AC isoforms, 9 membrane-bound and 1
soluble (Willoughby and Cooper, 2007). This discovery turned the established paradigm
of the cAMP system on its head. It rapidly emerged that these ACs are constrained to
distinct regions within the plasma membrane, opening the door to the idea that cAMP
signaling is compartmentalized within the cell (Houslay, 2009).
Now no man is an island, and if my scientific education has taught me nothing else,
neither is an enzyme. As Newton’s third law attests for every action an equal and opposite
reaction, there naturally exists a family of enzymes which are the yin to adenylyl cyclase’s
yang. These are the cyclic nucleotide phosphodiesterases (PDE) which degrade the
phosphodiester bond in the second messengers cAMP and cGMP, returning them to their
acyclic forms 5’-AMP and 5’-GMP (Wang, 2007). Sequestered PDE isoforms act in
concert with AC, albeit in an opposing manner, to sculpt gradients of cAMP, generating
signal compartmentalization and revealing the presence of discrete signaling complexes



 

within cells which are termed cAMP microdomains (Houslay, 2009). The discovery,
acceptance, and proof of theory of cAMP microdomains was pivotal in understanding the
inexplicably diverse effects cAMP could exert within the environment of a single cell.
The organization and regulation of cAMP microdomains are incredibly intricate
and detailed and their discussion could fill another thesis entirely. Rather than diving deep
into the complexities of the cAMP microdomains I would rather discuss their implications
within the paradigm of ICER and the ovary, which is after all what this research is about.
The many PDE family members and their isoforms have numerous different localizations
and functions. Of utmost significance to the research at hand are the PDE3 and PDE4
families. Oocytes predominantly express the PDE3 family, and inhibition of PDE3A
blocks oocyte maturation, while PDE3A-deficient mice ovulate a normal number of
oocytes but are infertile because their oocytes fail to undergo spontaneous maturation
(Vezzosi and Bertherat, 2011; Wang, 2007). Furthermore, research into PDE3 inhibitors in
primates showed a dose-dependent ability of PDE3 inhibitors to block the resumption of
meiosis in macaque oocytes, suggesting the possibility of PDE3 inhibitors to function as
contraceptives (Jensen et al., 2002).
PDE4D is expressed in granulosa cells and is critically important to the ovarian
follicle. Inhibition of PDE4 in follicle culture causes oocyte maturation in the absence of
gonadotropin stimulation, while subcutaneous injection of PDE4 inhibitors induced
ovulation in rats (Vezzosi and Bertherat, 2011). Additionally, PDE4 inhibition in FSHprimed rats induced ovulation in the absence of LH or hCG, indicating the possible function
of PDE4 inhibitors as a substitute for LH or hCG in ovulation, and when coadministered
with a subeffective dose of hCG, PDE4 inhibitors enhanced the ovulatory response



 

(McKenna et al., 2005). However, mice which are deficient in PDE4D exhibit delayed
growth, decreased viability, and reduced female fertility. PDE4D null females show
impaired ovulation and a diminished sensitivity of the granulosa cells to gonadotropins (Jin
et al., 1999). The ablation of the PDE4D gene caused the formation of luteinized
unruptured follicles with entrapped oocytes in mouse models again leading to infertility
(Park et al., 2003). Basically the inactivation of the cAMP/PDE4D regulatory feedback
loop disrupts the correct coordination of the pattern of gene expression and ovulation in
response to gonadotropin-induced cAMP elevation. Rather than being transiently elevated,
the consistent elevation of cAMP leads to desensitization of the gonadotropin receptors to
further signaling, inducing premature luteinization without oocyte release causing
infertility. The role of ICER, the only cAMP inducible repressor of cAMP-dependent gene
expression in the ovary, in relation to PDE3 and PDE4 remains to be studied. In fact, the
relative dearth of studies of ICER in the ovary is the basis for this research, which can
hopefully pave the way to further investigation of ICER in ovulation. However, in the
absence of specific evidence of ICER interactions with PDEs in the ovaries, data from the
cardiovascular system might provide some clues as to the effects of ICER in relation to
PDEs.
Yan, Miller, and Abe in a 2007 paper on the regulation of PDE3 and ICER in the
heart describe a PDE3A-ICER positive feedback loop, in which ICER represses PDE3A
gene transcription. In brief, CREB activation in response to cAMP induction, initiates
ICER expression. ICER then represses PDE3A expression, by interacting with CRE within
the PDE3A promoter. PDE3A downregulation leads to increased local cAMP
concentration, which activates PKA. PKA activation leads to more ICER protein elevation





completing the loop (Yan et al., 2007). Sustained ICER induction promotes cardiac
myocyte apoptosis by suppressing CREB-mediated transcription and survival protein Bcl2 expression (Ding et al., 2005; Yan, 2007). Angiotensin II (Ang II) and β−adrenergic
receptor agonist isoproterenol (ISO) utilize cAMP signaling to regulate contraction,
growth, and cell death in cardiac myocytes. Chronic exposure to Ang II and ISO promote
cardiac dysfunction through the PDE3A-ICER positive feedback loop (Ding, 2005; Yan,
2007).

Fig. 10 Scheme of the PDE3A-ICER feedback loop (Ding et al., 2005)
PDE3 inhibition in the reproductive system blocks the resumption of meiosis in
macaques and blocks oocyte maturation in mice causing infertility by an unknown
mechanism, while PDE3 inhibition via ICER induction in the cardiovascular system
promotes cardiac myocyte apoptosis, causing heart failure (Jensen, 2002; Vezzosi and
Bertherat, 2011; Wang, 2007; Ding, 2005; Yan, 2007). Based simply on this, the effects of
ICER overexpression in the ovary clearly deserve further study. Different tissues react
differently to ICER disequilibrium. Chronic reduction of ICER correlates with an increase
in CREB activity and expression of ATF3 in adipose tissues leading to systemic insulin





resistance in obese mice (Favre et al., 2011). ICER protein levels were found to be
significantly reduced in prostate cancer cells and undetectable and uninducible by cAMP
in a prostate tumor cell line (Yehia et al., 2001). Clearly ICER antagonism of CREB, as
well as PDE, represents a dynamic system of temporally and spatially restricted gene
expression important in diverse tissues, systems and processes. Further investigation of the
role of ICER in fertility, and its relationship with PDEs in the ovary, can hopefully lead to
new discoveries and deeper understanding of the ovulatory process. Although still limited,
the data on ICER induction in mice supports the notion that ICER plays a major role in
ovulation. Therefore, further research into its role in zebrafish ovulation made possible by
the creation of an inducible ovarian specific ICER overexpression plasmid described
herein, may in the future lead to novel therapies in the field of reproductive medicine.





REFERENCES
1. Aytekin, Y., & Yüce, R. (2008). Ovary maturatıon stages and histological
investigation of ovary of the Zebrafish (Danio rerio). Brazilian Archives of
Biology and Technology, 51(3), 513-522.
2. Bodor, J., Bodorova, J., & Gress, R. E. (2000). Suppression of T cell function: a
potential role for transcriptional repressor ICER. Journal of leukocyte
biology, 67(6), 774-779.
3. Cheshenko, K., Brion, F., Le Page, Y., Hinfray, N., Pakdel, F., Kah, O., ... &
Eggen, R. I. (2007). Expression of zebra fish aromatase cyp19a and cyp19b genes
in response to the ligands of estrogen receptor and aryl hydrocarbon
receptor. Toxicological sciences, 96(2), 255-267.
4. Clelland, E., & Peng, C. (2009). Endocrine/paracrine control of zebrafish ovarian
development. Molecular and cellular endocrinology, 312(1-2), 42-52.
5. Cooper, D. M. (2003). Regulation and organization of adenylyl cyclases and
cAMP. Biochemical Journal, 375(Pt 3), 517.
6. Ding, B., Abe, J. I., Wei, H., Xu, H., Che, W., Aizawa, T., ... & Berk, B. C.
(2005). A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible
cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proceedings of
the National Academy of Sciences of the United States of America, 102(41),
14771-14776.
7. Favre, D., Le Gouill, E., Fahmi, D., Verdumo, C., Chinetti-Gbaguidi, G., Staels,
B., … Abderrahmani, A. (2011). Impaired Expression of the Inducible cAMP
Early Repressor Accounts for Sustained Adipose CREB Activity in
Obesity. Diabetes, 60(12), 3169–3174. http://doi.org/10.2337/db10-1743
8. Foulkes, N. S., Schlotter, F., Pévet, P., & Sassone-Corsi, P. (1993). Pituitary
hormone FSH directs the CREM functional switch during
spermatogenesis. Nature, 362(6417), 264.
9. Goswami, D., & Conway, G. S. (2005). Premature ovarian failure. Human
reproduction update, 11(4), 391-410.
10.Hartenstein, V. (2006). The neuroendocrine system of invertebrates: a
developmental and evolutionary perspective. Journal of Endocrinology, 190(3),
555-570.
11.Hoo, J. Y., Kumari, Y., Shaikh, M. F., Hue, S. M., & Goh, B. H. (2016).
Zebrafish: a versatile animal model for fertility research. BioMed research
international, 2016.
12.Houslay, M. D. (2010). Underpinning compartmentalised cAMP signalling
through targeted cAMP breakdown. Trends in biochemical sciences, 35(2), 91100.
13.Howe, K., Clark, M. D., Torroja, C. F., Torrance, J., Berthelot, C., Muffato, M., ...
& McLaren, S. (2013). The zebrafish reference genome sequence and its
relationship to the human genome. Nature, 496(7446), 498.
14.Hull, M. G., Glazener, C. M., Kelly, N. J., Conway, D. I., Foster, P. A., Hinton, R.
A., ... & Desai, K. M. (1985). Population study of causes, treatment, and outcome
of infertility. Br Med J (Clin Res Ed), 291(6510), 1693-1697.





15.Hunzicker-Dunn, M., & Maizels, E. T. (2006). FSH signaling pathways in
immature granulosa cells that regulate target gene expression: branching out from
protein kinase A. Cellular signalling, 18(9), 1351-1359.
16.Jensen, J. T., Schwinof, K. M., Zelinski-Wooten, M. B., Conti, M., DePaolo, L.
V., & Stouffer, R. L. (2002). Phosphodiesterase 3 inhibitors selectively block the
spontaneous resumption of meiosis by macaque oocytes in vitro. Human
Reproduction, 17(8), 2079-2084.
17.Jin, S. L. C., Richard, F. J., Kuo, W. P., D’Ercole, A. J., & Conti, M. (1999).
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4Ddeficient mice. Proceedings of the National Academy of Sciences, 96(21), 1199812003.
18.Kawakami, K. (2007). Tol2: a versatile gene transfer vector in
vertebrates. Genome biology, 8(1), S7.
19.Kazeto, Y., Ijiri, S., Place, A. R., Zohar, Y., & Trant, J. M. (2001). The 5′flanking regions of CYP19A1 and CYP19A2 in zebrafish. Biochemical and
biophysical research communications, 288(3), 503-508.
20.Kwan, K. M., Fujimoto, E., Grabher, C., Mangum, B. D., Hardy, M. E.,
Campbell, D. S., ... & Chien, C. B. (2007). The Tol2kit: a multisite gatewaybased
construction kit for Tol2 transposon transgenesis constructs. Developmental
dynamics, 236(11), 3088-3099.
21.Kwok, H. F., So, W. K., Wang, Y., & Ge, W. (2005). Zebrafish gonadotropins
and their receptors: I. Cloning and characterization of zebrafish folliclestimulating hormone and luteinizing hormone receptors—evidence for their
distinct functions in follicle development. Biology of reproduction, 72(6), 13701381.
22.Li, C. W., & Ge, W. (2013). Regulation of the activin-inhibin-follistatin system
by bone morphogenetic proteins in the zebrafish ovary. Biology of
reproduction, 89(3), 55-1.
23.Lin, S. Y., Phillips, D. J., & de Kretser, D. M. (2003). Regulation of ovarian
function by the TGF-beta superfamily and follistatin. Reproduction, 126(2), 133148.
24.Lonze, B. E., & Ginty, D. D. (2002). Function and regulation of CREB family
transcription factors in the nervous system. Neuron, 35(4), 605-623.
25.Maheshwari, A., Hamilton, M., & Bhattacharya, S. (2008). Effect of female age
on the diagnostic categories of infertility. Human reproduction, 23(3), 538-542.
26.Maitra, S., Das, D., Ghosh, P., Hajra, S., Roy, S. S., & Bhattacharya, S. (2014).
High cAMP attenuation of insulin-stimulated meiotic G2-M1 transition in
zebrafish oocytes: interaction between the cAMP-dependent protein kinase (PKA)
and the MAPK3/1 pathways. Molecular and cellular endocrinology, 393(1-2),
109-119.
27.Martin, A. C. L., & Cooper, D. M. F. (2006). Layers of organization of cAMP
microdomains in a simple cell.
28.Mascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G.
A. (2012). National, regional, and global trends in infertility prevalence since
1990: a systematic analysis of 277 health surveys. PLoS medicine, 9(12),
e1001356.





29.Mayr, B., & Montminy, M. (2001). Transcriptional regulation by the
phosphorylation-dependent factor CREB. Nature reviews Molecular cell
biology, 2(8), 599.
30.Mazón, M. J., Gómez, A., & Zanuy, S. (2011). Follicle stimulating hormone
activates the steroidogenic process via cAMP/PKA and MAP-kinase pathways in
the ovary of European sea bass (Dicentrarchus labrax). Indian Journal of Science
and Technology, 4(S8), 190-191.
31.McClintock, B. (1950). The origin and behavior of mutable loci in
maize. Proceedings of the National Academy of Sciences, 36(6), 344-355.
32.McKenna, S. D., Pietropaolo, M., Tos, E. G., Clark, A., Fischer, D., Kagan, D., ...
& Palmer, S. (2005). Pharmacological inhibition of phosphodiesterase 4 triggers
ovulation in follicle-stimulating hormone-primed rats. Endocrinology, 146(1),
208-214.
33.Meyer, T. E., & Habener, J. F. (1993). Cyclic adenosine 3′, 5′-monophosphate
response element binding protein (CREB) and related transcription-activating
deoxyribonucleic acid-binding proteins. Endocrine reviews, 14(3), 269-290.
34.Michael, M. D., Michael, L. F., & Simpson, E. R. (1997). A CRE-like sequence
that binds CREB and contributes to cAMP-dependent regulation of the proximal
promoter of the human aromatase P450 (CYP19) gene. Molecular and cellular
endocrinology, 134(2), 147-156.
35.Molina, C. A., Foulkes, N. S., Lalli, E., & Sassone-Corsi, P. (1993). Inducibility
and negative autoregulation of CREM: an alternative promoter directs the
expression of ICER, an early response repressor. Cell, 75(5), 875-886.
36.Mosher, W. D. (1988). Fecundity and infertility in the United States. American
journal of public health, 78(2), 181-182.
37.Muñiz, L. C., Yehia, G., Ratnakar, P. V., & Molina, C. A. Hyperovulation in an
ovarian-specific transgenic mouse model. Unpublished manuscript.
38.Nagahama, Y., & Yamashita, M. (2008). Regulation of oocyte maturation in
fish. Development, Growth & Differentiation, 50(s1).
39.Park, J. Y., Richard, F., Chun, S. Y., Park, J. H., Law, E., Horner, K., ... & Conti,
M. (2003). Phosphodiesterase regulation is critical for the differentiation and
pattern of gene expression in granulosa cells of the ovarian follicle. Molecular
Endocrinology, 17(6), 1117-1130.
40.Poon, S. K., So, W. K., Yu, X., Liu, L., & Ge, W. (2009). Characterization of
inhibin α subunit (inha) in the zebrafish: evidence for a potential feedback loop
between the pituitary and ovary. Reproduction, 138(4), 709-719.
41.Popovics, P., Rekasi, Z., Stewart, A. J., & Kovacs, M. (2011). Regulation of
pituitary inhibin/activin subunits and follistatin gene expression by GnRH in
female rats. Journal of Endocrinology, 210(1), 71-79.
42.Sands, W. A., & Palmer, T. M. (2008). Regulating gene transcription in response
to cyclic AMP elevation. Cellular signalling, 20(3), 460-466.
43.Sassone-Corsi, P. (1998). Coupling gene expression to cAMP signalling: role of
CREB and CREM. The international journal of biochemistry & cell
biology, 30(1), 27-38.





44.Segner, H. (2009). Zebrafish (Danio rerio) as a model organism for investigating
endocrine disruption. Comparative Biochemistry and Physiology Part C:
Toxicology & Pharmacology, 149(2), 187-195.
45.Selman, K., Wallace, R. A., Sarka, A., & Qi, X. (1993). Stages of oocyte
development in the zebrafish, Brachydanio rerio. Journal of morphology, 218(2),
203-224.
46.So, W. K., Kwok, H. F., & Ge, W. (2005). Zebrafish gonadotropins and their
receptors: II. Cloning and characterization of zebrafish follicle-stimulating
hormone and luteinizing hormone subunits—their spatial-temporal expression
patterns and receptor specificity. Biology of reproduction, 72(6), 1382-1396.
47.Stehle, J. H., Foulkes, N. S., Molina, C. A., Simonneaux, V., Pévet, P., &
Sassone-Corsi, P. (1993). Adrenergic signals direct rhythmic expression of
transcriptional represser CREM in the pineal gland. Nature, 365(6444), 314.
48.Steward, R. G., Lan, L., Shah, A. A., Yeh, J. S., Price, T. M., Goldfarb, J. M., &
Muasher, S. J. (2014). Oocyte number as a predictor for ovarian hyperstimulation
syndrome and live birth: an analysis of 256,381 in vitro fertilization
cycles. Fertility and sterility, 101(4), 967-973.
49.Tanaka, M., Fukada, S., Matsuyama, M., & Nagahama, Y. (1995). Structure and
promoter analysis of the cytochrome P-450 aromatase gene of the teleost fish,
medaka (Oryzias latipes). The Journal of Biochemistry, 117(4), 719-725.
50.Thisse, B., Heyer, V., Lux, A., Alunni, V., Degrave, A., Seiliez, I., ... & Thisse, C.
(2004). Spatial and temporal expression of the zebrafish genome by large-scale in
situ hybridization screening. In Methods in cell biology (Vol. 77, pp. 505-519).
Academic Press.
51.Tong, S. K., & Chung, B. C. (2003). Analysis of zebrafish cyp19 promoters. The
Journal of steroid biochemistry and molecular biology, 86(3-5), 381-386.
52.Vaegter, K. K., Lakic, T. G., Olovsson, M., Berglund, L., Brodin, T., & Holte, J.
(2017). Which factors are most predictive for live birth after in vitro fertilization
and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100
prospectively recorded variables in 8,400 IVF/ICSI single-embryo
transfers. Fertility and sterility, 107(3), 641-648.
53.Vezzosi, D., & Bertherat, J. (2011). Phosphodiesterases in endocrine physiology
and disease. European journal of endocrinology, 165(2), 177-188.
54.Walker, W. H., & Habener, J. F. (1996). Role of transcription factors CREB and
CREM in cAMP-regulated transcription during spermatogenesis. Trends in
Endocrinology & Metabolism, 7(4), 133-138.
55.Wang, Y., & Ge, W. (2004). Developmental profiles of activin βA, βB, and
follistatin expression in the zebrafish ovary: evidence for their differential roles
during sexual maturation and ovulatory cycle. Biology of reproduction, 71(6),
2056-2064.
56.Wang, Z., Shi, F., Jiang, Y. Q., LU, L. Z., Wang, H., Watanabe, G., & Taya, K.
(2007). Changes of cyclic AMP levels and phosphodiesterase activities in the rat
ovary. Journal of Reproduction and Development, 53(4), 717-725.
57.Willoughby, D., & Cooper, D. M. (2007). Organization and Ca2+ regulation of
adenylyl cyclases in cAMP microdomains. Physiological reviews, 87(3), 9651010.





58.Woods, I. G., Kelly, P. D., Chu, F., Ngo-Hazelett, P., Yan, Y. L., Huang, H., ... &
Talbot, W. S. (2000). A comparative map of the zebrafish genome. Genome
research, 10(12), 1903-1914.
59.Yan, C., Miller, C. L., & Abe, J. (2007). Regulation of Phosphodiesterase 3 and
Inducible cAMP Early Repressor in the Heart. Circulation Research, 100(4),
489–501. http://doi.org/10.1161/01.RES.0000258451.44949.d7
60.Yehia, G., Razavi, R., Memin, E., Schlotter, F., & Molina, C. A. (2001). The
expression of inducible cAMP early repressor (ICER) is altered in prostate cancer
cells and reverses the transformed phenotype of the LNCaP prostate tumor cell
line. Cancer research, 61(16), 6055-6059.
61.Zhang, Z., Zhu, B., & Ge, W. (2015). Genetic analysis of zebrafish gonadotropin
(FSH and LH) functions by TALEN-mediated gene disruption. Molecular
Endocrinology, 29(1), 76-98.
62.Zon, L. I., & Peterson, R. T. (2005). In vivo drug discovery in the
zebrafish. Nature reviews Drug discovery, 4(1), 35.






